Accueil
Détail de l'auteur
Auteur B. KILMER |
Documents disponibles écrits par cet auteur (34)
Ajouter le résultat dans votre panier Faire une suggestion Affiner la recherche
Rapport
B. KILMER ; J. P. CAULKINS ; B. M. BOND ; P. H. REUTER | Santa Monica, CA : Rand Corporation | Occasional Papers | 2010U.S. demand for illicit drugs creates markets for Mexican drug trafficking organizations (DTOs) and helps foster violence in Mexico. This paper examines how marijuana legalization in California might influence DTO revenues and the violence in Me[...]Article : Périodique
Collecting information about the prevalence of cannabis use is necessary but not sufficient for understanding the size, dynamics, and outcomes associated with cannabis markets. This paper uses two data sets describing cannabis consumption in the[...]Article : Périodique
BACKGROUND AND AIMS: Supervised consumption sites (SCS) operate in more than 10 countries. SCS have mostly emerged as a bottom-up response to crises, first to HIV/AIDS and now overdose deaths, in ways that make rigorous evaluation difficult. Opi[...]Article : Périodique
J. P. CAULKINS ; A. TALLAKSEN ; J. TAYLOR ; B. KILMER ; P. REUTER |The 2000-2001 and the 2022-2023 Taliban opium bans were and could be two of the largest ever disruptions to a major illegal drug market. To help understand potential implications of the current ban for Europe, this paper analyzes how opioid mark[...]Article : Périodique
B. PARDO ; J. TAYLOR ; J. CAULKINS ; P. REUTER ; B. KILMER |BACKGROUND: Overdose deaths related to illegal drugs in North American markets are now dominated by potent synthetic opioids such as fentanyl, a circumstance foreshadowed by often-overlooked events in Estonia since the turn of the century. Marke[...]Rapport
NICOSIA N. ; R. L. PACULA ; B. KILMER ; R. LUNDBERG ; J. CHIESA | Santa Monica, CA : Rand Corporation | Monograph series | 2009This first national estimate suggests that the economic cost of methamphetamine (meth) use in the United States reached $23.4 billion in 2005. Given the uncertainty in estimating the costs of meth use, this book provides a lower-bound estimate o[...]Rapport
B. PARDO ; J. TAYLOR ; J. P. CAULKINS ; B. KILMER ; P. REUTER ; B. D. STEIN | Santa Monica, CA : Rand Corporation | Research Reports | 2019Deaths involving synthetic opioids in the United States increased from roughly 3,000 in 2013 to more than 30,000 in 2018. In fact, synthetic opioids like fentanyl are now involved in twice as many deaths as heroin. This book offers a systematic [...]Rapport
B. KILMER ; J. P. CAULKINS ; R. L. PACULA ; P. H. REUTER | Santa Monica, CA : Rand Corporation | Occasional Papers | 2012Discussions about reducing the harms associated with drug use and antidrug policies are often politicized, infused with questionable data, and unproductive. This paper provides a nonpartisan primer that should be of interest to those who are new[...]Article : Périodique
Background and aims: Prohibitions on producing, distributing and selling cannabis are loosening in various jurisdictions around the world. This paper describes the diversification of cannabis supply laws and discusses the challenges to and oppor[...]NouveautéRapport
The European Drugs Strategy concentrates on demand reduction and supply reduction through international cooperation and research, information and evaluation. However, efforts to provide insight in the different aspects of Europe's illicit drug p[...]Article : Périodique
R. SMART ; J. P. CAULKINS ; B. KILMER ; S. DAVENPORT ; G. MIDGETTE |Aims: To (1) assess trends and variation in the market share of product types and potency sold in a legal cannabis retail market and (2) estimate how potency and purchase quantity influence price variation for cannabis flower. Design: Secondar[...]Rapport
B. KILMER ; S. S. EVERINGHAM ; J. P. CAULKINS ; G. MIDGETTE ; R. L. PACULA ; P. H. REUTER ; R. M. BURNS ; B. HAN ; R. LUNDBERG | Santa Monica, CA : Rand Corporation | Research Reports | 2014In January 2012, the U.S. White House Office of National Drug Control Policy (ONDCP) asked RAND to generate national estimates of the total number of users, total expenditures, and total consumption for four illicit drugs from 2000 to 2010: coca[...]Rapport
G. MIDGETTE ; S. DAVENPORT ; J. P. CAULKINS ; B. KILMER | Santa Monica, CA : Rand Corporation | Research Reports | 2019Research questions: How many people are using cocaine (including crack), heroin, marijuana, and methamphetamine in the United States? How much are they using? How much money are they spending? How have these quantities changed over time? [...]Article : Périodique
There has been relatively little effort at cross-national analysis of data concerning drug policy, though there is growing variation in how nations deal with illegal drugs. Systematic accounts of barriers to, and opportunities for, making compar[...]Chapitre
R. L. PACULA ; R. J. MACCOUN ; P. REUTER ; J. CHRIQUI ; B. KILMER ; K. HARRIS ; L. PAOLI ; C. SCHAFER | Bingley [UK] : Emerald Group | Advances in Health Economics and Health Services Research | 2005Although frequently discussed as a singular policy, there is tremendous variation in the laws and regulations surrounding so-called decriminalization policies adopted by Werstern countries, with many jurisdictions adopting depenalization policie[...]